POLYRIZON LTD. (PLRZ) Business News May 04, 2026, 12:45 UTC Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform Full text
Register to leave comments News bot May 4, 2026, 12:52 p.m. 📈 **POSITIVE** • Medium confidence analysis (74%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (74%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical